MediChain is a Big-Data Medical platform. A system proposed by the development team, and this allows patients to keep their own data outside the chain in the appropriate geographic domain, and grant access to doctors and specialists everywhere, regardless of the payer network or EMR used.
A patient, doctor, and hospital will certainly be able to enter data into the MediChain and blockchain ecosystems to store one of the instructions and rules on usage and anonymity, while the data itself is kept out of the chain. Even more important is a patient can access his data and give permission to a doctor and other hospitals to access certain parts of the data that go beyond the individual electronic medical record system.
Researchers and pharmaceutical companies will access the data as large data in an anonymous form. It is monetized by the ability to voluntarily provide anonymous access to unspecified data to pharmaceutical companies, researchers, and insurance companies. Potential can also be used for prescription management.
When and wherever data is collected on a patient, by a medical expert, issuing a prescription or even the purchase of a non-prescription drug, a patient through an app, this will certainly be an opportunity to have a reference or pointer added to Blockchain Ethereum - a digital ledger decentralized. So a blockchain is a
index to storage and contains hashes that validate offchain data.
An innovation provided by MediChain in electronic medical records (EMRs) by providing an open source API that is free to add MediChain to any EMR without regulatory constraints. MediChain Is a solution that suits the needs of patients, community persecution, and medical researchers. This adds a new, decentralized recording management system to EMR using blockchain technology to manage authentication, confidentiality, accountability and data sharing while storing off-chain data in secure clouds.
PLANNING
The MediChain work system will be developed on the Ethereum framework with offchain data stored in secure clouds in the appropriate region. It will initially be launched in conjunction with a number of medical specialties such as epilepsy and rheumatology and certain diagnostic devices. The next phase will build a chain data warehouse through open access APIs and medical partnerships. MediChain will then be made public through the API as well as through partners for data acquisition. Then the exchange will be developed to allow secure access of anonymous data to be controlled to patient data.
MediChain Utility Tokens (MCU)
MCU represents an arbitrary patient data block value. MCU Utility Tokens can be purchased through platforms during token sales. The basic rule is that initially, data from any consultation or arbitrary data deduction is rated in the MCU equal to the buyer's consulting fee in the US. Over time this value is adjusted to the availability of tokens, data types, diseases, demographics of the patient and others, to reflect the buyer's market. Data is available (subject to regulation and anonymization) through one or more markets to buyers.
A total of 46.5% token will be released, 6.5% on presale, 40% in main sale. There are no plans to release any more tokens. The remaining commitments can be solved by pool sales or partnerships.
Before presale there will be a Sales Founder without Softcap. Bonus of 50% is available for all purchase levels at that time.
Token Generation Event (TGE)
Event Token Generation ("TGE") will be allocated as follows:
1. Pre-Sale Maximum 6.5%
2. General Sales 40%
3. Partners Fund 15%
4. Fund Team & Founder 18%
5. Counselor 6.5%
6. Medical Data Fund 10%
7. Bounty 4%
1 MCU for $ 1
All unsold tokens will be burned
Preliminary presale for the first 5 million MCUs issued
Bonus during Pre-Sale
500K MCU, bonus of 50%
200K MCU, bonus of 45%
100K MCU, bonus of 35%
20K MCU, bonus of 25%
10K MCU, bonus of 20%
5K MCU, bonus of 15%
1K MCU, bonus of 10%
For information on the sales phase, visit the official website
Website | ANN | Facebook | Twitter | Telegram Group | Linkedin
Author: Awan biru
Tidak ada komentar:
Posting Komentar